cellular myelocytomatosis oncogene(English)

• functions during LVAD as a regulator of the fibroblast-to-endothelial cell fate transition, offering a mechanistic entry point to develop regenerative therapies in heart failure. Also as cMYC
• cMYC, HF, HFR, LVAD, MEndoT
• Cardiology, Therapeutic approaches, Medical technology (assessment), Regulation / control
• https://doi.org…NAHA.125.078996